BAVARIA, GERMANY, March 02, 2011 (Press-News.org) BELECTRIC Trading GmbH has signed a three-year contract with Solar Frontier to sell and install Solar Frontier's proprietary CIS modules at a volume in the three-digit megawatt range, which will be produced primarily at Solar Frontier's new gigawatt-scale facility in Miyazaki, Japan. Solar Frontier's CIS modules have the competitive advantage of combining economical production with an intrinsically ecological technology. In combination with the Solar Frontier specialist sales and support team, BELECTRIC Trading will be able to apply its extensive expertise in planning and constructing solar installations while offering its customers high-performance thin-film solutions.
"Our visit of the gigawatt-scale production facilities in Miyazaki, Japan, exceeded all our expectations and we are convinced that Solar Frontier's CIS modules are ideal for our clients," said Martin Zembsch, Managing Director, BELECTRIC Trading Germany. The partnership will be an important step toward a prosperous future for the company. "Apart from the leading technology, important decision criteria were the giga-scale production capacity, expert consultancy and the sales support of the European Solar Frontier team. We are certain that this partnership between Solar Frontier and BELECTRIC Trading will help drive CIS to a leading position in the European thin-film market."
BELECTRIC is a pioneer in the photovoltaic industry, bringing great benefit to CIS and Solar Frontier. The Kolitzheim, Germany-based company is one of the few companies globally which implements free-field and roof installations. At the same time, BELECTRIC is considered a pioneer as regards service and innovation.
"I am very pleased that after recently signing agreements with two global companies, we are collaborating with BELECTRIC Trading, the world's largest solar EPC (engineering, procurement and construction) provider," said Wolfgang Lange, Managing Director, Solar Frontier Europe. "Belectric Trading is an important strategic partner in our European expansion strategy with an outstanding expertise and track record. This contract is the start of a long-term cooperation and will initially focus on distribution with a volume in the three-digit range over three years."
BELECTRIC: BELECTRIC Trading GmbH (formerly Blitzstrom GmbH) is an international distributor of photovoltaic system components. The company is part of the BELECTRIC brand and offers customers worldwide its know-how and cost advantages achieved by a common sourcing strategy and the expertise of the BELECTRIC engineers.
Solar Frontier K.K.: Solar Frontier, a 100% subsidiary of Showa Shell Sekiyu K.K., established the world's first gigawatt-scale CIS module factory in 2011 with a mission to create the most economical, ecological solar energy solutions in the world, on the world's largest scale.
Showa Shell Sekiyu K.K.: Showa Shell Sekiyu K.K. is listed on the Tokyo Stock Exchange and has roots dating back more than 100 years in the downstream energy business.
Website: http://www.belectric.com
BELECTRIC Trading and Solar Frontier: Strategic Partnership for Triple-Digit Megawatt Sales
BELECTRIC Trading GmbH has signed a three-year contract with Solar Frontier to sell and install Solar Frontier's proprietary CIS modules at a volume in the three-digit megawatt range.
2011-03-02
ELSE PRESS RELEASES FROM THIS DATE:
Certain parts of the brain activated in people who heard tailored health messages and quit smoking
2011-03-01
ANN ARBOR, Mich.---People who demonstrated a stronger brain response to certain brain regions when receiving individually tailored smoking cessation messages were more likely to quit smoking four months after, a new study found.
The new University of Michigan study underscores the importance of delivering individually tailored public health messages to curb unhealthy behaviors, said principal investigator Hannah Faye Chua, who led the study as a research assistant professor at the U-M School of Public Health. It also begins to uncover the underlying neural reasons why ...
Researchers from Hebrew U., US discover how mercury gets into fish we eat
2011-03-01
Jerusalem, February 27, 2011 -- Researchers from the Hebrew University of Jerusalem and the US have discovered the mechanism whereby dangerous mercury eventually finds its way into the fish we eat from the open seas and oceans.
The researchers, Prof. Menachem Luria from the Fredy and Nadine Herrmann Institute of Earth Sciences at the Hebrew University and Dr. Daniel Obrist of the University of Nevada, found that "passive" mercury normally found in the atmosphere is converted into an "active," oxidized form in the presence of bromine. The passive mercury is generally ...
Experts propose global guidelines for safe use of Kava and new Australian study
2011-03-01
Medical and scientific experts propose a global framework for the safe production and use of the medicinal plant Kava, including further clinical testing In Australia.
The South-Pacific plant has been traditionally used to reduce stress and anxiety but is restricted in some countries.
Leading world Kava experts Dr Jerome Sarris from the University of Melbourne, Australia; Professor Rolf Teschke from Wolfgang Goethe-University, Frankfurt, Germany; and Dr Vincent Lebot from CIRAD, Port-Vila, Vanuatu, have proposed a six-point plan that is intended to become the framework ...
More evidence that Alzheimer's disease may be inherited from your mother
2011-03-01
ST. PAUL, Minn. – Results from a new study contribute to growing evidence that if one of your parents has Alzheimer's disease, the chances of inheriting it from your mother are higher than from your father. The study is published in the March 1, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
"It is estimated that people who have first-degree relatives with Alzheimer's disease are four to 10 times more likely to develop the disease themselves compared to people with no family history," said study author Robyn Honea, DPhil, of ...
Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue
2011-03-01
BOSTON, Feb. 28, 2011 – In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir – two promising approaches for preventing HIV in women – researchers found that daily use of the vaginal gel achieved a more than 100-times higher concentration of active drug in vaginal tissue than did the oral tablet, while, compared to the gel, the tablet used daily was associated with a 20-times higher active drug concentration in blood.
Results of the Phase II trial, which examined differences in drug absorption as well as women's preferences for each ...
Tenofovir gel provides high level of protection against HIV in rectal tissue
2011-03-01
BOSTON, Feb. 28, 2011 – A gel developed to protect against HIV during vaginal sex produced a strong antiviral effect when used in the rectum, according to an early-phase study presented today at the 18th Conference on Retroviruses and Opportunistic Infections (CROI). The results, based on rectal tissue biopsies sampled from HIV-negative men and women who used the product daily for one week, provide the first-ever evidence that tenofovir gel could help reduce the risk of HIV from anal sex, even though the vaginal gel formulation may not be optimal for rectal use.
Tenofovir ...
Heart attack patients with depression less likely to receive priority care in emergency rooms
2011-03-01
Heart attack patients with a history of depression presenting at emergency departments were less likely to receive priority care than people with other conditions, found a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100685.pdf.
Several studies indicate that people with heart attacks and depression have worse outcomes than people without, although emergency department care has not been looked at as a possible contributor. In the United States, more than six million patients with mental health issues ...
The influence of advertising on drug recommendations
2011-03-01
A medical journal's revenue source can affect drug recommendations, with free journals positively recommending specific drugs while journals funded solely by subscriptions usually recommending against the use of the drugs, states a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100951.pdf.
Little is known about corporate influence on educational medical journals, although physicians rely heavily on journals for continuing medical information. Many of these journals, which rely solely on advertising ...
Gene variant affects stroke prognosis in humans
2011-03-01
A small difference in DNA sequence predicts the degree of disability after a stroke, according to a paper published online on February 28 in the Journal of Experimental Medicine (www.jem.org). Stroke, the consequence of disturbed blood flow to the brain, can impair speech, movement and vision, but it is currently difficult for clinicians to predict the severity of these side effects or the long-term prognosis.
Strokes result in the death of brain cells called neurons. Angeles Almeida and co-workers found that variations in a gene known to control cell death—Tp53—influence ...
Adult care for congenital heart disease patients should begin in adolescence
2011-03-01
Doctors should transition their patients from pediatric to adult medical care for congenital heart disease during early adolescence, experts recommend in a scientific statement published in Circulation: Journal of the American Heart Association.
"It's not as simple as getting the name of a new doctor and going to see them when a patient turns 18," said Craig Sable, M.D., co-chair of the statement committee and director of echocardiography and cardiology fellowship training at Children's National Medical Center in Washington, D.C. "There are multiple steps associated ...
LAST 30 PRESS RELEASES:
Making lighter work of calculating fluid and heat flow
Normalizing blood sugar can halve heart attack risk
Lowering blood sugar cuts heart attack risk in people with prediabetes
Study links genetic variants to risk of blinding eye disease in premature infants
Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain
AI can pick up cultural values by mimicking how kids learn
China’s ecological redlines offer fast track to 30 x 30 global conservation goal
Invisible indoor threats: emerging household contaminants and their growing risks to human health
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Germline pathogenic variants among women without a history of breast cancer
Tanning beds triple melanoma risk, potentially causing broad DNA damage
Unique bond identified as key to viral infection speed
Indoor tanning makes youthful skin much older on a genetic level
Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy
The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025
Smarter tools for peering into the microscopic world
Applications open for funding to conduct research in the Kinsey Institute archives
Global measure underestimates the severity of food insecurity
Child survivors of critical illness are missing out on timely follow up care
Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial
University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage
Early relapse predicts poor outcomes in aggressive blood cancer
American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement
Clinical trial finds cannabis use not a barrier to quitting nicotine vaping
Supplemental nutrition assistance program policies and food insecurity
Switching immune cells to “night mode” could limit damage after a heart attack, study suggests
URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment
Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events
Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors
[Press-News.org] BELECTRIC Trading and Solar Frontier: Strategic Partnership for Triple-Digit Megawatt SalesBELECTRIC Trading GmbH has signed a three-year contract with Solar Frontier to sell and install Solar Frontier's proprietary CIS modules at a volume in the three-digit megawatt range.